| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2016-05-27 01:26:33 UTC |
|---|
| Update Date | 2016-11-09 01:22:28 UTC |
|---|
| Accession Number | CHEM041390 |
|---|
| Identification |
|---|
| Common Name | Dihomo-gamma-Linolenoyl ethanolamide |
|---|
| Class | Small Molecule |
|---|
| Description | |
|---|
| Contaminant Sources | |
|---|
| Contaminant Type | Not Available |
|---|
| Chemical Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| 8,11,14-Eicosatrienoylethanolamide | ChEBI | | Anandamide (20.3,N-6) | ChEBI | | HGLEA | ChEBI | | Homo-gamma-linolenylethanolamide | ChEBI | | N-(8Z,11Z,14Z-Eicosatrienoyl)-ethanolamine | ChEBI | | N-(8Z,11Z,14Z-Icosatrienoyl)-ethanolamide | ChEBI | | Homo-g-linolenylethanolamide | Generator | | Homo-γ-linolenylethanolamide | Generator | | Dihomo-g-linolenoylethanolamide | Generator | | Dihomo-γ-linolenoylethanolamide | Generator | | Homo-gamma-linolenoyl ethanolamide | MeSH | | dihomo-g-Linolenoyl ethanolamide | Generator, HMDB | | dihomo-γ-linolenoyl ethanolamide | Generator, HMDB | | (8Z,11Z,14Z)-N-(2-Hydroxyethyl)icosa-8,11,14-trienamide | HMDB | | DGLA ea | HMDB | | dihomo-gamma-Linolenoylethanol amide | HMDB | | Dihomo-g-linolenoyl-ea | Generator | | Dihomo-γ-linolenoyl-ea | Generator |
|
|---|
| Chemical Formula | C22H39NO2 |
|---|
| Average Molecular Mass | 349.551 g/mol |
|---|
| Monoisotopic Mass | 349.298 g/mol |
|---|
| CAS Registry Number | 150314-34-4 |
|---|
| IUPAC Name | (8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-8,11,14-trienamide |
|---|
| Traditional Name | hglea |
|---|
| SMILES | CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(=O)NCCO |
|---|
| InChI Identifier | InChI=1S/C22H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,24H,2-5,8,11,14-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12- |
|---|
| InChI Key | ULQWKETUACYZLI-QNEBEIHSSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic nitrogen compounds |
|---|
| Class | Organonitrogen compounds |
|---|
| Sub Class | Amines |
|---|
| Direct Parent | N-acylethanolamines |
|---|
| Alternative Parents | |
|---|
| Substituents | - N-acylethanolamine
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Alcohol
- Organooxygen compound
- Primary alcohol
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | - N-(polyunsaturated fatty acyl)ethanolamine (CHEBI:34488 )
- N-(long-chain-acyl)ethanolamine (CHEBI:34488 )
- N-acyl ethanolamides (endocannabinoids) (C13828 )
- N-acyl ethanolamines (endocannabinoids) (LMFA08040011 )
|
|---|
| Biological Properties |
|---|
| Status | Detected and Not Quantified |
|---|
| Origin | Not Available |
|---|
| Cellular Locations | Not Available |
|---|
| Biofluid Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | Not Available |
|---|
| Applications | Not Available |
|---|
| Biological Roles | Not Available |
|---|
| Chemical Roles | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Appearance | Not Available |
|---|
| Experimental Properties | | Property | Value |
|---|
| Melting Point | Not Available | | Boiling Point | Not Available | | Solubility | Not Available |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | | Spectrum Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-029g-8983000000-42e4744911acb250a34f | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (1 TMS) - 70eV, Positive | splash10-00y0-9573200000-a8db30d9ff9f0147625e | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0w29-5149000000-90d7161272eec6776994 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03dl-9121000000-76079fc33c97f5136a62 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-03dl-9230000000-71d39c754ceca5b22f18 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0002-0009000000-70187c5620a575618c1e | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-01pk-5019000000-7d063e287364f13a7e93 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0006-9010000000-756ebbaf8f5db95a9d3c | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0002-0009000000-25e88f7ed1f5fc19f31f | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0002-5129000000-b4eff9f1d3f5b681b725 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-052f-9010000000-3b5498e873ffa2327ed5 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0w29-9228000000-3de5ffd9870259f4c489 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03dl-9000000000-55cab8b86efb0346a9ef | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-01ox-9100000000-50506e85794f343a8424 | Spectrum |
|
|---|
| Toxicity Profile |
|---|
| Route of Exposure | Not Available |
|---|
| Mechanism of Toxicity | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Toxicity Values | Not Available |
|---|
| Lethal Dose | Not Available |
|---|
| Carcinogenicity (IARC Classification) | Not Available |
|---|
| Uses/Sources | Not Available |
|---|
| Minimum Risk Level | Not Available |
|---|
| Health Effects | Not Available |
|---|
| Symptoms | Not Available |
|---|
| Treatment | Not Available |
|---|
| Concentrations |
|---|
| Not Available |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB0013625 |
|---|
| FooDB ID | FDB029602 |
|---|
| Phenol Explorer ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PDB ID | Not Available |
|---|
| Wikipedia Link | Not Available |
|---|
| Chemspider ID | 4445443 |
|---|
| ChEBI ID | 34488 |
|---|
| PubChem Compound ID | 5282272 |
|---|
| Kegg Compound ID | C13828 |
|---|
| YMDB ID | Not Available |
|---|
| ECMDB ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| MSDS | Not Available |
|---|
| General References | | 1. Tripathy S, Kleppinger-Sparace K, Dixon RA, Chapman KD: N-acylethanolamine signaling in tobacco is mediated by a membrane-associated, high-affinity binding protein. Plant Physiol. 2003 Apr;131(4):1781-91. | | 2. Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN: Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol. 2002 May;34(5):509-18. | | 3. Hofmann U, Domeier E, Frantz S, Laser M, Weckler B, Kuhlencordt P, Heuer S, Keweloh B, Ertl G, Bonz AW: Increased myocardial oxygen consumption by TNF-alpha is mediated by a sphingosine signaling pathway. Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2100-5. Epub 2003 Jan 30. | | 4. Amadou A, Nawrocki A, Best-Belpomme M, Pavoine C, Pecker F: Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes. Am J Physiol Cell Physiol. 2002 Jun;282(6):C1339-47. | | 5. Anton M, Rodriguez-Gonzalez A, Rodriguez-Rojo IC, Pastor A, Correas A, Serrano A, Ballesta A, Alen F, Gomez de Heras R, de la Torre R, Rodriguez de Fonseca F, Orio L: Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women. Addict Biol. 2018 Nov;23(6):1242-1250. doi: 10.1111/adb.12580. Epub 2017 Nov 27. |
|
|---|